INTEGRA LIFESCIENCES HOLDINGS CORP (IART) FY2026 Q2 Balance Sheet

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

3,563,490,000 US dollars

Current assets

1,191,482,000 US dollars

Non-current assets

2,372,008,000 US dollars

Liabilities

2,520,113,000 US dollars

Current liabilities

330,881,000 US dollars

Non-current liabilities

2,189,232,000 US dollars

Equity

1,043,377,000 US dollars

Inventories, net

492,005,000 US dollars

Trade accounts receivable, net of allowances of $7,326 and $7,230

267,188,000 US dollars

Cash and cash equivalents

214,415,000 US dollars

Prepaid expenses

104,344,000 US dollars

Short-term investments

59,669,000 US dollars

Other current assets

53,861,000 US dollars

Intangible assets, net

1,075,542,000 US dollars

Goodwill

611,145,000 US dollars

Property, plant and equipment, net

446,202,000 US dollars

Right of use asset - operating leases

137,085,000 US dollars

Deferred tax assets, net

70,443,000 US dollars

Other assets

31,591,000 US dollars

Accrued expenses and other current liabilities

107,618,000 US dollars

Accounts payable, trade

82,637,000 US dollars

Accrued compensation

68,177,000 US dollars

Current portion of borrowings under senior credit facility

43,594,000 US dollars

Current portion of lease liability - operating leases

13,920,000 US dollars

Contract liabilities

11,699,000 US dollars

Income tax payable

3,236,000 US dollars

Current portion of borrowings under securitization facility

0 US dollars

Long-term borrowings under senior credit facility

1,736,105,000 US dollars

Other liabilities

194,397,000 US dollars

Lease liability - operating leases

162,660,000 US dollars

Long-term borrowings under securitization facility

92,600,000 US dollars

Deferred tax liabilities

3,470,000 US dollars

Additional paid-in capital

1,346,265,000 US dollars

Retained earnings

423,306,000 US dollars

Common stock; $0.01 par value; 240,000 authorized shares; 92,130 and 92,286 issued at June 30, 2026 and December 31, 2025, respectively

921,000 US dollars

Preferred stock; no par value; 15,000 authorized shares; none outstanding

0 US dollars

Treasury stock, at cost; 14,351 shares and 14,399 shares at June 30, 2026 and December 31, 2025, respectively

negative 686,918,000 US dollars

Accumulated other comprehensive loss

negative 40,197,000 US dollars

Gross equity (calculated)

1,770,492,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.